Capsaicin-sensitive sensory neurons regulate myocardial nitric oxide and cGMP signaling

2003 ◽  
Vol 476 (1-2) ◽  
pp. 107-113 ◽  
Author(s):  
Tamás Csont ◽  
Csaba Csonka ◽  
Péter Kovács ◽  
Gábor Jancsó ◽  
Péter Ferdinandy
2018 ◽  
Vol 46 (9) ◽  
pp. e945-e954 ◽  
Author(s):  
Francisco Vasques-Nóvoa ◽  
Tiago L. Laundos ◽  
Rui J. Cerqueira ◽  
Catarina Quina-Rodrigues ◽  
Ricardo Soares-dos-Reis ◽  
...  

2011 ◽  
Vol 89 (2) ◽  
pp. 89-95 ◽  
Author(s):  
Ercan Ozdemir ◽  
Ihsan Bagcivan ◽  
Nedim Durmus ◽  
Ahmet Altun ◽  
Sinan Gursoy

Although the phenomenon of opioid tolerance has been widely investigated, neither opioid nor nonopioid mechanisms are completely understood. The aim of the present study was to investigate the role of the nitric oxide (NO)–cyclic guanosine monophosphate (cGMP) pathway in the development of morphine-induced analgesia tolerance. The study was carried out on male Wistar albino rats (weighing 180–210 g; n = 126). To develop morphine tolerance, animals were given morphine (50 mg/kg; s.c.) once daily for 3 days. After the last dose of morphine was injected on day 4, morphine tolerance was evaluated. The analgesic effects of 3-(5′-hydroxymethyl-2′-furyl)-1-benzylindazole (YC-1), BAY 41-2272, S-nitroso-N-acetylpenicillamine (SNAP), NG-nitro-l-arginine methyl ester (L-NAME), and morphine were considered at 15 or 30 min intervals (0, 15, 30, 60, 90, and 120 min) by tail-flick and hot-plate analgesia tests (n = 6 in each study group). The results showed that YC-1 and BAY 41-2272, a NO-independent activator of soluble guanylate cyclase (sGC), significantly increased the development and expression of morphine tolerance, and L-NAME, a NO synthase (NOS) inhibitor, significantly decreased the development of morphine tolerance. In conclusion, these data demonstrate that the nitric oxide–cGMP signal pathway plays a pivotal role in developing tolerance to the analgesic effect of morphine.


Nitric Oxide ◽  
2015 ◽  
Vol 46 ◽  
pp. 157-164 ◽  
Author(s):  
Koji Takeuchi ◽  
Fumitaka Ise ◽  
Kento Takahashi ◽  
Eitaro Aihara ◽  
Shusaku Hayashi

2009 ◽  
Vol 12 (6) ◽  
pp. 1411-1415 ◽  
Author(s):  
Ana Paula Corrêa Castelo Branco Nap Arruda ◽  
Roberta Gomes Coelho ◽  
Neli Kika Honda ◽  
Catharine Ferrazoli ◽  
Arnildo Pott ◽  
...  

Neuron ◽  
1992 ◽  
Vol 9 (2) ◽  
pp. 315-324 ◽  
Author(s):  
Daniel S. McGehee ◽  
Michael F. Goy ◽  
Gerry S. Oxford

2012 ◽  
Vol 111 (suppl_1) ◽  
Author(s):  
Yuchuan Liu ◽  
Abdelkarim Sabri ◽  
Louis Dell'Italia ◽  
Victor Rizzo ◽  
Emily J Tsai

Volume-overload (VO), as seen in regurgitant valvular disease, large myocardial infarction, and severe cardiac systolic dysfunction, triggers eccentric hypertrophy. Given that nitric oxide (NO) and cyclic guanosine monophosphate (cGMP) modulate cardiomyocyte hypertrophy, apoptosis, and cardioprotection, differential regulation of these signals may distinguish eccentric from the more commonly studied concentric hypertrophy. We recently showed that pressure-overload (PO) induces relocalization and oxidation of the NO receptor soluble guanylyl cyclase (sGC), thereby diminishing cyclase activity and cGMP cardioprotection. The effects of volume-overload on NO and cGMP signaling are unknown. We tested the hypothesis that VO induces relocalization but not oxidation of sGC, thereby disrupting spatial regulation of NO-cGMP signaling without depressing cyclase activity. Volume-overload was established by chordal rupture-induced mitral regurgitation in dogs. We compared intracellular localization and activity of sGC in VO and control LVs (N=5 per group). Both sGC subunits were detected within and outside of caveolae-enriched lipid raft microdomains (Cav3+LR). In VO hearts, sGCβ1 fell in expression by nearly 50% and relocalized away from Cav3+LR to non-lipid raft microdomains (NLR). Despite VO-induced sGCβ1 changes, overall NO-stimulated sGC activity was preserved. An enhanced response to heme/NO-independent sGC activator BAY 60-2770 suggested that a subset of sGC was heme-oxidized in VO hearts, though to a much lesser degree than in PO hearts. As in PO hearts, Cav3+LR appear to protect sGC from heme-oxidation in VO hearts. Initial study of downstream reactive nitrogen species (RNS) and cGMP signaling supported our theory that VO altered spatial regulation of NO-cGMP signaling. Also, a trend towards increased overall tyrosine-nitration, predominantly within NLR, was observed in VO hearts. Volume-overload shifted cardiac NO-cGMP signaling from Cav3+LR to NLR microdomains without depressing NO/heme-dependent sGC activation. These findings suggest that differential spatial regulation of NO/RNS signaling, rather than simply increased RNS signaling, might drive the distinct molecular pathophysiology of eccentric hypertrophy.


2002 ◽  
Vol 90 (4) ◽  
Author(s):  
Hanke Mollnau ◽  
Maria Wendt ◽  
Katalin Szöcs ◽  
Bernard Lassègue ◽  
Eberhard Schulz ◽  
...  

2011 ◽  
Vol 31 (12) ◽  
pp. 2827-2835 ◽  
Author(s):  
Priya Handa ◽  
Sanshiro Tateya ◽  
Norma O. Rizzo ◽  
Andrew M. Cheng ◽  
Vicki Morgan-Stevenson ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document